The sperm scandal in Halland, western Sweden, is heading to court after Region Halland refused to pay damages to four people who say they were affected by past failures at the county’s former insemination unit in Halmstad.
Why the Sweden sperm scandal is now in court
Region Halland says it will not pay compensation without a judicial ruling, arguing that Swedish case law offers little guidance for damages claims in a case that is both unique and rooted in events that took place decades ago.
The dispute is now expected to be decided by Halmstad District Court (Halmstad tingsrätt), following a joint claim filed by two men who say they became biological fathers without consent and two donor-conceived individuals who say missing or incorrect donor records have affected their right to know their origins.
What happened at Halmstad’s former insemination unit
According to Region Halland’s own reviews, semen samples originally provided for fertility investigations were wrongly used for donor insemination at the former county hospital in Halmstad—today Halland Hospital (Hallands sjukhus). The shortcomings concern an activity that operated from the 1970s to the 1990s, with documentation gaps and weak oversight also highlighted in later years.
The case became public after investigative reporting by SVT’s programme Uppdrag granskning and subsequent internal and external reviews. Region Halland has said the historical handling of the insemination activity included serious deficiencies in documentation, routines and follow-up, and that not all details can be reconstructed given the time elapsed.
The damages claim and what the plaintiffs are asking for
The four claimants are seeking SEK 100,000 each (about €9,400) in damages, for a total of SEK 400,000 (about €37,600).
Their legal argument, according to reporting in Sweden, is built around the right to privacy and personal integrity under the European Convention on Human Rights (Europakonventionen). The claim is being pursued with support from the Centre for Justice (Centrum för rättvisa), a Swedish legal foundation known for strategic litigation.
One of the men involved, Bengt Wernersson, has said he has wanted the case tested in court for years and hopes for a clear legal assessment—even though the underlying events date back more than three decades.
Region Halland’s response: “A judicial review is needed”
Region Halland’s chief medical officer (chefläkare), Anders Åkvist, has said the region sees a need for a court test because the circumstances are unusual and because any decision on compensation should be grounded in a stable legal principle.
In its public statements, the region has also pointed to a practical concern: it needs a framework it can rely on in the future, given that the fallout from the case continues to affect people who contact the hospital and the region for information, DNA testing and support.
A European human-rights dimension—and the problem of time
A key complication is the time period involved. Region Halland has described the insemination activity as occurring long ago, making the facts difficult to investigate and the legal questions harder to frame.
The issue has also reached the European Court of Human Rights (Europadomstolen). Region Halland has said that two people previously submitted complaints to the Strasbourg court, and that in June 2025 the court indicated that any legal review should first take place in Swedish courts.
The Halland case therefore sits at the intersection of healthcare governance, consent, and the long-term consequences of inadequate record-keeping—issues that Nordic public healthcare systems, often built on high trust, have had to confront in recent years.
What happens next in Halland—and what it could mean for Sweden
The court proceedings will now determine whether damages are available, on what legal basis, and how responsibility should be assessed when public institutions acknowledge serious past failures but argue that compensation requires clearer precedent.
Whatever the outcome, the case is likely to influence how Swedish regions handle similar historical claims, and how donor-conceived individuals and former patients seek accountability. It may also strengthen calls for clearer national standards on documentation, traceability and safeguards in fertility and assisted reproduction services—areas where patients’ rights increasingly collide with complex questions about privacy, identity and consent.
